Kai Zhou

6.9k citations
206 papers · 4.8k indexed · 3 hit papers · h-index 36

Kai Zhou

196 papers receiving 4.8k citations

Hit Papers

Indole-3-Acetic Acid Alters Intes...1122016202620192022100200300400

Peers

Kai Zhou
Comparison fields: 5 of 171
  • Molecular Medicine 1.1k
  • Endocrinology 557
  • Biological Psychiatry 252
  • Applied Microbiology and Biotechnology 131
  • Clinical Biochemistry 278
Replace Qingping Wu with:
Qingping Wu China
Kok‐Gan Chan Malaysia
Mohsin Khurshid Pakistan
Uri Gophna Israel
Peter W. Taylor United Kingdom
Yu Ding China
Cormac G. M. Gahan Ireland
Paal Skytt Andersen Denmark
Stanley Brul Netherlands
Hsin‐Chih Lai Taiwan
Kai Zhou relative to Qingping Wu China Qingping Wu's profile →
Citations per field
00.5×2.8×
Qingping Wu · 1×
Citations per year

Countries citing papers authored by Kai Zhou

Since Specialization
Citations

This map shows the geographic impact of Kai Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Zhou more than expected).

Fields of papers citing papers by Kai Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Zhou. The network helps show where Kai Zhou may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kai Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kai Zhou Line = papers co-authored together Kai Zhou links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20251
3 202424
4 20249
5 20240
6 20240
7 202433
8 20243
9 20240
10 20245
11 20235
12 20236
13 202310
14 20222
15 20217
16 202116
17 202197
18 202128
19 202047
20 201768

About Kai Zhou

Kai Zhou is a scholar working on Molecular Medicine, Endocrinology and Aquatic Science, having authored 206 papers that have together received 4.8k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (46 papers), Aquaculture Nutrition and Growth (12 papers), Pharmaceutical and Antibiotic Environmental Impacts (12 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers), Bacterial biofilms and quorum sensing (11 papers), Vibrio bacteria research studies (11 papers), Physiological and biochemical adaptations (10 papers) and Influenza Virus Research Studies (9 papers). The work is most often cited by research in Molecular Medicine (1.1k citations), Endocrinology (557 citations) and Biological Psychiatry (252 citations). Kai Zhou has collaborated with scholars based in China, Netherlands and Australia. Frequent co-authors include John W. A. Rossen, Lanjuan Li, Ping Shen, Yonghong Xiao, Alexander W. Friedrich, Qixia Luo, Abram Aertsen, Chris W. Michiels, Baohong Wang and A.M.D. Kooistra-Smid. Their work appears in journals such as Scientific Reports, Frontiers in Microbiology, Emerging Microbes & Infections, International Journal of Antimicrobial Agents and Frontiers in Cellular and Infection Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026